The North America Antimicrobial Susceptibility Testing market was valued at USD 1,814.88 Million in 2022 and is expected to reach USD 2,827.80 Million by 2030, growing at a CAGR of 5.7% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.